Lbt Innovations (ASX: CC5) Share Price and News

Price

$0.029

Movement

0.00 (0.0)

as at 10 Nov 11:36am (20 mins delayed)

52 Week Range

$0.012 - $0.037

 
1 Year Return

+93.33%

Lbt Innovations Chart and Price Data

$0.00
$0.02
$0.04
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04

Fundamentals Data provided by Morningstar.

Share Price

$0.029

Day Change

0.00 (0.0)

52 Week Range

$0.012 - $0.037

Yesterday's Close

$0.029

Today's Open

$0.029

Days Range

$0.028 - $0.029

Volume

601,198

Avg. Volume (1 month)

2,235,306

Turnover

$17,114

as at 10 Nov 11:36am

  • Lbt Innovations (ASX: CC5)
    Latest News

    A woman jumps for joy with a rocket drawn on the wall behind her.
    Healthcare Shares

    Guess which small cap ASX stock is rocketing 80% today

    What is getting investors excited on Wednesday? Let's find out.

    Read more »

    A young woman with her mouth open and her hands out showing surprise and delight as uranium share prices skyrocket
    Healthcare Shares

    Guess which ASX AI stock rocketed 170% on an AstraZeneca update

    Investors are loving this company's announcement on Wednesday.

    Read more »

    doctor looks out window resting head in hand
    Healthcare Shares

    LBT Innovations (ASX:LBT) share price plummets 14% despite positive update

    The company's shares are off to a bad start this week...

    Read more »

    Healthcare Shares

    Why the LBT Innovations share price is charging higher today

    The LBT Innovations Limited (ASX: LBT) share price is storming higher today after the company announced the first sale of…

    Read more »

    a woman
    Speculative

    Why the LBT Innovations share price rocketed 243% higher on Tuesday

    The LBT Innovations Limited (ASX:LBT) share price was an impressive performer on Tuesday, rising a staggering 243% at one stage...

    Read more »

    a woman
    Investing

    3 fast-growing biotech shares at the top of my watch list

    CSL Limited (ASX:CSL) is the king of biotech shares, but could one of these three fledgling biotechs one day sit…

    Read more »

    a woman
    Investing

    Here's why LBT Innovations Limited shares rocketed 89% today

    LBT Innovations Limited (ASX:LBT) shares are soaring after gaining FDA approval for its Automated Plate Assessment System. But is it…

    Read more »

    Investing

    What investors can learn from LBT Innovations Limited's slump to a seven-month low

    LBT Innovations Limited's (ASX:LBT) painful crash today on news that its French partner is pursuing another interest holds lessons for…

    Read more »

    a woman
    Investing

    4 stocks that soared more than 16% today

    A fall in the ASX index today couldn't spoil these four stocks' day in the sun

    Read more »

    CC5 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    7th Nov 2025 2025-11-07T18:51:01 Application for quotation of securities - CC5YesNo6:51pm616k
    6th Nov 2025 2025-11-06T11:02:45 Application for quotation of securities - CC5YesNo11:02am616k
    31st Oct 2025 2025-10-31T17:19:56 Application for quotation of securities - CC5YesNo5:19pm616k
    30th Oct 2025 2025-10-30T09:20:13 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:20am9433k
    21st Oct 2025 2025-10-21T11:29:01 Becoming a substantial holderYesNo11:29am2383k
    21st Oct 2025 2025-10-21T11:25:26 Application for quotation of securities - CC5YesNo11:25am616k
    17th Oct 2025 2025-10-17T09:32:12 Letter to Option HoldersYesNo9:32am3344k
    14th Oct 2025 2025-10-14T09:44:57 Notice of Annual General Meeting/Proxy FormYesNo9:44am15772k
    2nd Oct 2025 2025-10-02T15:51:53 Change in substantial holdingYesNo3:51pm2669k
    2nd Oct 2025 2025-10-02T08:26:55 Change in substantial holdingYesNo8:26am2460k

    About Lbt Innovations

    LBT Innovations Ltd. is an Australian developer of clinical and diagnostic technology, which has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefits for busy clinical laboratories. The firm operates its business through research and development segments. The company was founded by Lusia Halina Guthrie, Douglas Peter LeMessurier and Paul Andrew Mariani in 2004 and is headquartered in Adelaide, Australia.

    Profile

    since

    Note